Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q2 FY27 Earnings Presentation
22 slides from Narayana Hrudayalaya's earnings presentation, Nov 2, 2026
Slide 1: Submission letter to stock exchanges: revised investor presentation
Date of submission: November 02, 2026 To, To, The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Mumbai – 400 051 Dalal Street, Mumbai
Slide 2: Earnings Update Q2 FY27
fib ‘Narayana Health Earnings Update Q2 FY27
Slide 3: Index
Topic Slide No. Our Footprint 03 Narayana Health at a Glance 04 Q2 FY27 Highlights 05 Index Capex 16 Digital Initiatives 17 Narayana Health ESG Vision – “Health For All” 18 Shareholding Pattern 19 2
Slide 4: Our Footprint (as on 1st October 2026)
Our Footprint (as on 1st October 2026) United Kingdom India Ophthalmology Centers Hospitals/ Surgical Centers Diagnostic Centers Hospitals/Surgical Centers + Delhi NCR Urgent Treatment Centers Barlborough Jaipur Rochdale Guwahati Lincolnshire Birmingham Buckinghamshire Ahmedabad Jamshedpur Emersons
Slide 5: Narayana Health – At a Glance
Narayana Health – At a Glance Total Capacity Beds 6,374 Facility Details No. of Facilities Operational Beds South (India) Hospitals - 7 | Heart Centres - 2 | Clinics - 15 | Diagnostic Centre - 1 India – Hospitals and Heart Centres 21 5,624 Operational Beds - 2,159 (Hospitals) and 132 (HC) India - Cl
Slide 6: Key Highlights – Operational & Financial Performance (Q2 FY27)
Key Highlights – Operational & Financial Performance (Q2 FY27) ▪ Narayana Institute of Cardiac Sciences, Bengaluru has performed : • South India’s first Percutaneous Transcatheter Tricuspid Valve Replacement (TTVR) • India’s first Transcatheter Tricuspid Valve Implantation (TTVI) on a 14-year-old •
Slide 7: India Operations – Revenue (Q2 FY27)
India Operations – Revenue (Q2 FY27) ₹ Mn Total* 14,000 Domestic 13,442 20,004 13,500 C 186 13,196 14,388 13,000 12,552 15,004 12,331 12,500 C 171 9.0% QoQ 11,863 10,004 12,000 H 13,256 C 156 11,500 H 12,381 5,004 H 11,707 11,000 4 10,500 Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 16.7% YoY H -
Slide 8: India Hospital – Revenue Mix (Q2 FY27)
India Hospital – Revenue Mix (Q2 FY27) Business Mix(4,7) Specialty-Profile(4,7) Payor-Profile(4,7) 7% 17% 25% 33% 18% 5% 43% 8% 1% 74% 9% 1% 14% 15% 33% Cardiac Sciences Medicine and GI sciences Owned Hospitals (1) Domestic Walk-in patients Oncology (2) Operated Hospitals Renal Sciences Insured Pati
Slide 9: India Hospitals – Operations Review (Q2 FY27)
India Hospitals – Operations Review (Q2 FY27) Average Revenue Per Patient (IP & OP) (1,2) ALOS ₹ ‘000 Days 162.6 163.4 4.5 149.4 4.3 4.3 4.3 4.3 OP 4.1 IP 3.9 4.8 5.1 5.2 3.7 Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Patient Footfalls (IP & OP)(1,3) 110 ICU Occupied Bed Days ‘000 800 ‘000 102
Slide 10: India Hospitals – Cluster Split (Q2 FY27)
India Hospitals – Cluster Split (Q2 FY27) This considers owned/operated hospitals & heart centers in India Southern Eastern Western Bangalore Kolkata Northern Peripheral Peripheral • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram Regions • MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • N
Slide 11: India Hospitals – Profitability Snapshot (Q2 FY27)
India Hospitals – Profitability Snapshot (Q2 FY27) Includes NH India Hospitals EBITDA and EBITDA Margin (1) 5,000 Cost Structure ₹ ‘Mn 4,500 % of Operating Revenues Chart Title Rental / Revenue Share (7) 4,000 26.8% 2% 2% 2% 3,500 24.8% (1) 26.0% (2) 100% 23.8% 11% 10% 10% 3,000 90% 23.4% (2) 80% (5
Slide 12: India Insurance – Key Financial Summary
India Insurance – Key Financial Summary ₹ Mn Financial Parameters Q2 FY27 Q2 FY26 Gross Written Premium 78 70 Reinsurance Premium -3 -3 Net Written Premium 75 67 Change in Reserve 57 -33 Net Earned Premium 133 34 Net Incurred Claims 211 25 Net Commission 3 -0 Total Operating Expenses 93 65 Investmen
Slide 13: Cayman Islands (Q2 FY27)
Cayman Islands (Q2 FY27) Hospital Revenues Insurance Revenues (CIHL) US$ Mn US$ Mn 54.0 49.3 20.0 16.8 15.4 49.0 44.8 15.0 44.0 41.6 9.3 39.0 10.0 9.9% QoQ 8.8% QoQ 34.0 5.0 29.0 24.0 0.0 Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 18.4% YoY 80.2% YoY Hospital & Insurance – EBITDA Discharges & O
Slide 14: United Kingdom (Q2 FY27)
United Kingdom (Q2 FY27) Hospital Revenues EBITDA Pre-IFRS GBP Mn GBP Mn 74.0 67.6 6.0 65.0 64.4 4.8 64.0 5.0 4.0 3.3 54.0 3.0 44.0 -0.9% QoQ 1.9 2.0 34.0 1.0 -41.7% QoQ 24.0 0.0 Q4 FY26 Q1 FY27 Q2 FY27 Q4 FY26 Q1 FY27 Q2 FY27 EBITDA Post-IFRS EBITDA Margin (Post-IFRS) 8.0 GBP Mn 7.1 12.0% 10.5% 5.7
Slide 15: Consolidated Financial Performance (Q2 FY27)
Consolidated Financial Performance (Q2 FY27) Figures in ₹ Mn, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (₹ Mn) Q2 FY27 Q2 FY26 Particulars 30th Sep 2026 Total Operating Revenue 28,440 16,438 Shareholder Equity 50,054 Consumption 5,477 3,222 Borrowing
Slide 16: Financial Summary (Q2 FY27)
Financial Summary (Q2 FY27) Particulars Q2 FY27 Q1 FY27 Q2 FY26 QoQ Growth% YOY Growth% NH India (₹ Mn) Operating Revenue 14,402 13,247 12,347 ▲ 8.7% ▲ 16.6% EBITDA 3,548 2,901 2,712 ▲ 22.3% ▲ 30.8% PAT 1,899 1,317 1,395 ▲ 44.2% ▲ 36.2% 13.2% 9.9% 11.3% HCCI ($ Mn) Operating Revenue 63.4 58.2 49.5 ▲
Slide 17: Expansion: Progress Status & Capex Strategy
Expansion: Progress Status & Capex Strategy Building to strengthen our presence in flagship regions Current Bed Capacity Bed Capacity Addition Bed Capacity Target 400 7,800+ 7,834 300 120 350 350 220 5,879 215 Capex Head (INR Mn) FY27 (P) FY27 (A) Greenfield/ 4,600 955 Inorganic Replacement/ 2,700 6
Slide 18: Digital Hospitals – Way Forward
Digital Hospitals – Way Forward B ANASHANKAR I · DIGITAL HOSPITA L OP Journey Outpatient 5 steps · all digital IP Journey Inpatient 6 steps · all digital Paperless Registration Upfront Cost Estimate Estimate built in ATHMA from package and per-day rates, shared with the family Kiosk or counter regis
Slide 19: NH ESG Vision – “Health For All”
NH ESG Vision – “Health For All” Actuals Q2 FY 26-27 (T=Target Q2 FY 26-27) A Healthy Planet By being conscious about impact on the environment, prioritizing consumption efficiency and resource optimization 50% Carbon Neutral 100% Optimized 30% less Renewable energy Waste-water recycling by 2030 Was
Slide 20: Shareholding Pattern
Shareholding Pattern As on 30th Sep 2026(1) ESOP Trust DIIs 0.7% Total Number of Shares 12.5% 204,360,804 FIIs 9.0% Key DIIs Key FIIs Mirae Asset Management Vanguard Index Fund Parag Parikh Asset Management Franklin Templeton Investment Funds Nippon Life India Asset Management Simcah Partners LP Oth
Slide 21: Disclaimer and Contact Details
Disclaimer and Contact Details No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as
Slide 22: Take Care
di. C Take Care